ESC 365 - Anticoagulation therapy in 2016 and beyond: from theory to practice.

Open Access

Anticoagulation therapy in 2016 and beyond: from theory to practice.

Session: Anticoagulants in cardiovascular disease – from basics to translation

Topic: Miscellaneous

Speaker: Doctor J. Weitz (Hamilton, CA)

Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

Add to my library

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

31 presentations

1 follower

5 more presentations in this session

Thrombosis revisited: the role of platelets and thrombin in venous and arterial thrombosis.

Speaker: Professor A. Siegbahn (Uppsala, SE)

NOACs for treatment of venous thromboembolism: where are we, and where are we going?

Speaker: Professor W. Ageno (Varese, IT)

NOACs in atrial fibrillation and coronary heart disease: where are we and where are we going?

Speaker: Professor R. De Caterina (Pisa, IT)

Monitoring NOACs: heresy or care refinement?

Speaker: Doctor M. Levi (Amsterdam, NL)

Reversal of non-vitamin K antagonist oral anticoagulants: true need or perception in search of solutions.

Speaker: Doctor J. Van Ryn (Biberach, DE)

Access the full session

Anticoagulants in cardiovascular disease – from basics to translation

Speakers: Doctor J. Weitz, Professor A. Siegbahn, Professor W. Ageno, Professor R. De Caterina, Doctor M. Levi...

About the event

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources